| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
 |
World Community Grid Forums
Category: Active Research
Forum: OpenPandemics - COVID-19 Project
Thread: Interesting News Articles About OPN1 - COVID-19 Novel Coronavirus |
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 572
|
|
| Author |
|
|
Landorin
Cruncher Germany Joined: Apr 28, 2007 Post Count: 31 Status: Offline Project Badges: 
|
Israeli study offers strongest proof yet of vitamin D’s power to fight COVID
----------------------------------------It might not prevent infection but "Israel scientists say they have gathered the most convincing evidence to date that increased vitamin D levels can help COVID-19 patients reduce the risk of serious illness or death." [...] "In June, researchers published preliminary findings showing that 26 percent of coronavirus patients died if they were vitamin D deficient soon before hospitalization, compared to 3% who had normal levels of vitamin D." https://www.timesofisrael.com/israeli-study-o...-ds-power-to-fight-covid/  |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 664 Status: Offline Project Badges: 
|
Study shows persistent antibodies in infants after COVID-19 vaccination in pregnancy: Antibody levels were lower in unvaccinated, COVID-infected mothers at delivery and in their infants - Science Daily
https://www.sciencedaily.com/releases/2022/02/220207124816.htm  |
||
|
|
Landorin
Cruncher Germany Joined: Apr 28, 2007 Post Count: 31 Status: Offline Project Badges:
|
SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses
----------------------------------------"Most of the millions of people that are vaccinated against SARS-CoV-2, the causative agent of COVID-19, have previously been infected by related circulating human coronaviruses (hCoVs) causing common colds and will experience further encounters with these viruses in the future" [...] "Methods: The study design and cohort of individuals aged 25-46 (median 30.5) years, who received a ChAdOx1 nCoV-19 prime (AstraZeneca shot) followed by a BNT162b2 (BionTech/Pfizer) boost has been reported. Presera were taken up to 2 days before prime vaccination and post-immunization sera 2 weeks after the BNT162b2 boost. [...] Prior SARS-CoV-2 infection was excluded by medical history and by measuring anti-SARS-CoV-2 nucleocapsid antibody levels for all but one reconvalescent individual." "Conclusion: Heterologous COVID-19 vaccination may confer some cross-protection against endemic seasonal coronaviruses." https://academic.oup.com/cid/advance-article/...ac057/6515378?login=false [Edit 3 times, last edit by Landorin at Feb 13, 2022 11:07:04 AM] |
||
|
|
Jim1348
Veteran Cruncher USA Joined: Jul 13, 2009 Post Count: 1066 Status: Offline Project Badges:
|
Op-Ed: The pandemic isn’t over. Omicron won’t be the last coronavirus variant to haunt us
Let’s hope our luck does not run out. Getting prepared for worst-case scenarios is our best defense, with better genomic, wastewater and digital tracking of the virus, and bolstering protection with everything from better air filtration to accelerating efforts for a variant-proof, pan-coronavirus vaccine. Better to be smart against this formidable virus than lucky. https://www.latimes.com/opinion/story/2022-02...s-covid-pandemic-vaccines Eric J. Topol is a professor of molecular medicine at Scripps Research and author of the newsletter Ground Truths. |
||
|
|
Jim1348
Veteran Cruncher USA Joined: Jul 13, 2009 Post Count: 1066 Status: Offline Project Badges:
|
New Omicron subvariant ‘Centaurus’ could be the most immune-evasive yet, expert warns
But experts are already raising potential red flags. Dr. Eric Topol, a professor of molecular medicine at Scripps Research and founder and director of the Scripps Research Translational Institute, said Monday the new subvariant's mutations "could make immune escape worse than what we're seeing now" with BA.5 and BA.4, subvariants known to evade immunity from both vaccination and prior infection. https://fortune.com/2022/07/06/new-omicron-su...on-immune-evasive-expert/ |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 664 Status: Offline Project Badges:
|
Answering patients' questions about the bivalent COVID-19 vaccine / American Medical Association
https://www.ama-assn.org/delivering-care/publ...bivalent-covid-19-vaccine |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 664 Status: Offline Project Badges:
|
IHME COVID-19 insights blog
Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine in the United States director and lead moderator Dr. Christopher J.L. Murray shares insights from their latest COVID-19 model run at the 72nd WHO Regional Committee for Europe, taking place in Tel Aviv, Israel. https://www.healthdata.org/news-events/blogs/covid-19-insights-blog |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 664 Status: Offline Project Badges:
|
Yale Epidemiologist Dr. Risch on the Devastating Failure of the Covid Public Health Policy
The Pulse of Israel https://pulseofisrael.com/2022/09/15/risch-covid-policy/ |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 664 Status: Offline Project Badges:
|
Audio Interview: Can Vaccines Prevent Transmission of Covid:19? | NEJM
https://www.nejm.org/doi/full/10.1056/NEJMe2212576?query=featured_home |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 664 Status: Offline Project Badges:
|
Assessing Bivalent Vaccines against Covid-19 | NEJM
https://www.nejm.org/doi/full/10.1056/NEJMe22...criber&bid=1183595474 |
||
|
|
|